“Corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry ...

Though infant mortality has continuously been targeted by health policy agendas, policies tend to place it in an individualistic and narrow frame, failing to consider and address its structural ...

A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...

Understanding today’s corporatization of U.S. health care requires seeing it from a historical perspective, as a process that began with a change in the business model of care delivery in the 1920s.

Cutaneous squamous-cell carcinoma (SCC) is primarily caused by oncogenesis mediated by ultraviolet radiation, and β-human papillomavirus (β-HPV) is believed to be a mere facilitator that is ...

Risks and rewards change during the life cycle of a drug. In the innovation period, drug companies invest in developing new products but cannot sell them. Newly approved drugs initially have exclus ...

Policy discussions related to affirmative action have typically focused on its effects on education, employment, and earnings. But affirmative action may also play a role in shaping population health.

This Double Take video explores the link between certain strains of human papillomavirus and cancer and reviews the evidence behind the HPV vaccine, as well as who should receive it and when.

Children were recently discovered to have been exposed to high levels of lead in Milwaukee schools — the latest episode in an ongoing toxic pandemic. This time, no help was forthcoming from the CDC.

Maintaining medicine’s commitment to excellence while remedying our failures requires distinguishing unnecessary trainee harms from necessary discomforts. Why is it so hard to make these ...

Much of the food consumed in the United States is ultraprocessed. Evidence indicates that ultraprocessed food, as a class, has contributed to high rates of chronic diseases.

Homozygosity for the PNPLA3 risk allele is linked to liver fat accumulation. In phase 1 trials, JNJ-75220795, a hepatocyte-targeted GalNAc-conjugated PNPLA3 siRNA, reduced liver fat in PNPLA3 ...